Study on the interaction effect and mechanism of food lipids and Maillard reaction products

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042753

Enrollment

Unknown

Registered

2021-01-27

Start date

2022-05-01

Completion date

Unknown

Last updated

2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

High exposure of Maillard reaction products intervention group:Fish oil capsules(GT type)

High exposure of Maillard reaction products control group:Placebo capsules

Low exposure of Maillard reaction products intervention group:Fish oil capsules(GT type)

Low exposure of Maillard reaction products control group:Placebo capsules

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: The criteria for determining overweight and obese patients followed the Chinese criteria for overweight and obesity (overweight: BMI >= 24; Obesity: BMI >= 28).

Exclusion criteria

Exclusion criteria: Blood Lipids TG >= 4.56 mmol/L. Who has proliferative retinopathy, is pregnant or lactating, is allergic to fish, smokes or drinks too much, has a history of heart disease, liver disease, kidney disease or cancer, and has participated in other clinical trials in recent 3 months.

Design outcomes

Primary

Measure	Time frame
BMI;blood lipid TG;	—

Countries

China

Contacts

Public ContactYu Zhang

Zhejiang University

y_zhang@zju.edu.cn+86 18267165125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026